Covestor’s Precigen PGEN Stock Holding History

Covestor’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1K	Buy	114 +80	+235%	+$346	﹤0.01%	2289
2026 Q1	$0	Buy	+34	New	+$140	﹤0.01%	2654
2022 Q1	–	Sell	-1	Closed	–	–	2353
2021 Q4	$0	Buy	+1	New	+$4	﹤0.01%	2249

Other funds holding PGEN

PCM

Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Covestor's PGEN Position: Q2 2026 in Review

Covestor increased its Precigen (PGEN) stake by 235% in Q2 2026, buying an estimated $346 and bringing the position to 114 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2289.

Covestor first reported a position in PGEN in Q4 2021 and has held it in 3 quarters since. 210 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

Covestor held 114 shares of Precigen worth $1K as of Q2 2026.
Covestor bought 80 Precigen shares in Q2 2026, an estimated $346.
Precigen made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #2289 holding.
Covestor first reported a position in Precigen in Q4 2021 and has held it in 3 quarters since.
210 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.